Odds Ratio: Biologic Use (95% CI) | p-value | Odds Ratio: Immunomodulator Use (95% CI) | p-value | Odds Ratio: 5-ASA Use (95% CI) | p-value | Odds Ratio: Corticosteroid Use (95% CI) | p-value | Odds Ratio: Opioid Use (95% CI) | p-value | |
---|---|---|---|---|---|---|---|---|---|---|
Gender | ||||||||||
Female (referent) | - | - | - | - | - | - | - | - | - | - |
Male | 1.22 (1.14–1.30) | <0.001 | 1.08 (1.02–1.14) | 0.006 | 1.18 (1.13–1.23) | <0.001 | 0.93 (0.90–0.98) | 0.002 | 0.85 (0.82–0.89) | <0.001 |
Age Group | ||||||||||
12 to 18 | 1.75 (1.56–1.97) | <0.001 | 1.85 (1.66–2.07) | <0.001 | 1.10 (0.98–1.24) | 0.09 | 1.33 (1.20–1.47) | <0.001 | 0.98 (0.89–1.08) | 0.71 |
19 to 30 (referent) | - | - | - | - | - | - | - | - | - | - |
31 to 45 | 0.60 (0.54–0.65) | <0.001 | 0.65 (0.60–0.71) | <0.001 | 0.79 (0.73–0.85) | <0.001 | 0.85 (0.80–0.91) | <0.001 | 1.09 (1.02–1.17) | 0.009 |
45 to 64 | 0.31 (0.28–0.34) | <0.001 | 0.50 (0.46–0.54) | <0.001 | 0.59 (0.55–0.63) | <0.001 | 0.62 (0.58–0.66) | <0.001 | 1.02 (0.96–1.09) | 0.55 |
Region | ||||||||||
Northeast (Referent) | - | - | - | - | - | - | - | - | - | - |
North Central | 1.32 (1.19–1.46) | <0.001 | 1.58 (1.45–1.73) | <0.001 | 1.79 (1.68–1.92) | <0.001 | 1.64 (1.54–1.75) | <0.001 | 1.69 (1.59–1.81) | <0.001 |
South | 1.31(1.19–1.44) | <0.001 | 1.28 (1.18–1.39) | <0.001 | 1.55 (1.46–1.64) | <0.001 | 1.72 (1.62–1.82) | <0.001 | 1.93 (1.82–2.04) | <0.001 |
West | 1.21 (1.07–1.36) | 0.001 | 1.29 (1.17–1.42) | <0.001 | 1.33 (1.25–1.43) | <0.001 | 1.21 (1.13–1.30) | <0.001 | 1.48 (1.48–1.69) | <0.001 |
Unknown | 1.28 (1.00–1.63) | 0.048 | 0.85 (0.67–1.08) | 0.18 | 0.74 (0.64–0.86) | <0.001 | 0.80 (0.69–0.93) | 0.005 | 0.91 (0.77–0.89) | 0.22 |
Insurance Type | ||||||||||
EPO/PPO (referent) | - | - | - | - | - | - | - | - | - | - |
HMO/Cap POS | 1.01 (0.91–1.11) | 0.91 | 1.15 (1.06–1.25) | 0.001 | 1.58 (1.47–1.70) | <0.001 | 1.28 (1.20–1.36) | <0.001 | 1.39 (1.30–1.48) | <0.001 |
POS | 1.09 (0.97–1.23) | 0.15 | 1.20 (1.09–1.34) | <0.001 | 1.27 (1.17–1.38) | <0.001 | 1.27 (1.17–1.37) | <0.001 | 1.23 (1.14–1.33) | <0.001 |
HDHP/CDHP | 1.21 (1.08–1.36) | 0.001 | 0.96 (0.86–1.07) | 0.44 | 1.43 (1.31–1.56) | <0.001 | 1.39 (1.28–1.50) | <0.001 | 1.10 (1.01–1.19) | 0.02 |
Comp | 0.82 (0.62–1.07) | 0.14 | 1.13 (0.93–1.38) | 0.23 | 1.47 (1.25–1.72) | <0.001 | 1.31 (1.13–1.53) | <0.001 | 1.49 (1.28–1.73) | <0.001 |
Grouped Charlson Index | ||||||||||
0 (referent) | - | - | - | - | - | - | - | - | - | - |
1 | 1.49 (1.38–1.62) | <0.001 | 1.33 (1.24–1.43) | <0.001 | 0.89 (0.84–0.94) | <0.001 | 1.43 (1.36–1.51) | <0.001 | 1.47 (1.39–1.55) | <0.001 |
2+ | 1.88 (1.72–2.06) | <0.001 | 1.65 (1.53–1.78) | <0.001 | 0.81 (0.76–0.85) | <0.001 | 1.46 (1.38–1.55) | <0.001 | 2.19 (2.06–2.32) | <0.001 |